Yourgene
Yourgene Posts Twofold Rise in FY 2022 Revenues
The Manchester, UK-based firm reported £37.6 million in revenues for fiscal year 2022, up from £18.2 million in 2021, with COVID-19 testing driving the increase.
Yourgene Health, Ambry Genetics Team on Genomic Services Under Extended Strategic Partnership
The firms are giving each other access to their technologies and assays, which will allow Ambry to include NIPT in its digital screening support product.
In Brief This Week: Roche, Seegene, SQI Diagnostics, Agilent Technologies, and More
News items for the in vitro diagnostics industry for the week of Feb. 14, 2022.
In Brief This Week: Quest Diagnostics, Beckman Coulter, Thermo Fisher Scientific, Diadem, and More
News items for the in vitro diagnostics industry for the week of Jan. 17, 2022.
Yourgene Inks Deal With EKF Diagnostics to Offer NIPT, Other Genomic Tests in US
Under the terms of the deal, EKF subsidiary Advanced Diagnostics Laboratory will offer an NIPT service in the US based on Yourgene's technology.
Oct 26, 2021
Yourgene H1 2022 Revenues More Than Double
Oct 26, 2020